APO RESEARCH · REPORT
Bacillus Coagulans
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
Product & engineering
Understand the product.
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
Selected research
Market Structure
Global Bacillus Coagulans Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
North America is the largest consumption place, with a consumption market share nearly 38.9% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 26.8%.
Market competition is intense. Kerry, Sabinsa, Mitsubishi, UAS Laboratories, Synbiotech, etc. are the leaders of the industry, with high-end customers
Read the full market overview
This report provides an overview of the global Bacillus Coagulans market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bacillus Coagulans and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bacillus Coagulans sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bacillus Coagulans market size, projected growth trends, production technologies, key applications, and end-use industries.
Bacillus Coagulans Segment by Company
Kerry
Sabinsa
Mitsubishi
UAS Laboratories
Synbiotech
Syngen Biotech
Sanzyme
Microbax
Bacillus Coagulans Segment by Type
Below 100 B
100-200 B
Above 200 B
Bacillus Coagulans Segment by Application
Drugs
Food and Beverage
Supplement Products
Bacillus Coagulans Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacillus Coagulans market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacillus Coagulans and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacillus Coagulans.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bacillus Coagulans market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacillus Coagulans manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bacillus Coagulans in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bacillus Coagulans in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Below 100 B
- 100-200 B
- Above 200 B
Applications
- Drugs
- Food and Beverage
- Supplement Products
Companies covered
- Kerry
- Sabinsa
- Mitsubishi
- UAS Laboratories
- Synbiotech
- Syngen Biotech
- Sanzyme
- Microbax
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bacillus Coagulans Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bacillus Coagulans Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Bacillus Coagulans Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Bacillus Coagulans Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Bacillus Coagulans Market Dynamics
- 2.1 Bacillus Coagulans Industry Trends
- 2.2 Bacillus Coagulans Industry Drivers
- 2.3 Bacillus Coagulans Industry Opportunities and Challenges
- 2.4 Bacillus Coagulans Industry Restraints
3 Bacillus Coagulans Market by Manufacturers
- 3.1 Global Bacillus Coagulans Revenue by Manufacturers (2021-2026)
- 3.2 Global Bacillus Coagulans Sales by Manufacturers (2021-2026)
- 3.3 Global Bacillus Coagulans Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Bacillus Coagulans Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bacillus Coagulans Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bacillus Coagulans Manufacturers, Product Type & Application
- 3.7 Global Bacillus Coagulans Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bacillus Coagulans Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bacillus Coagulans Players Market Share by Revenue in 2025
- 3.8.3 2025 Bacillus Coagulans Tier 1, Tier 2, and Tier 3
4 Bacillus Coagulans Market by Type
- 4.1 Bacillus Coagulans Type Introduction
- 4.1.1 Below 100 B
- 4.1.2 100-200 B
- 4.1.3 Above 200 B
- 4.2 Global Bacillus Coagulans Sales by Type
- 4.2.1 Global Bacillus Coagulans Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bacillus Coagulans Sales by Type (2021-2032)
- 4.2.3 Global Bacillus Coagulans Sales Market Share by Type (2021-2032)
- 4.3 Global Bacillus Coagulans Revenue by Type
- 4.3.1 Global Bacillus Coagulans Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bacillus Coagulans Revenue by Type (2021-2032)
- 4.3.3 Global Bacillus Coagulans Revenue Market Share by Type (2021-2032)
5 Bacillus Coagulans Market by Application
- 5.1 Bacillus Coagulans Application Introduction
- 5.1.1 Drugs
- 5.1.2 Food and Beverage
- 5.1.3 Supplement Products
- 5.2 Global Bacillus Coagulans Sales by Application
- 5.2.1 Global Bacillus Coagulans Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bacillus Coagulans Sales by Application (2021-2032)
- 5.2.3 Global Bacillus Coagulans Sales Market Share by Application (2021-2032)
- 5.3 Global Bacillus Coagulans Revenue by Application
- 5.3.1 Global Bacillus Coagulans Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bacillus Coagulans Revenue by Application (2021-2032)
- 5.3.3 Global Bacillus Coagulans Revenue Market Share by Application (2021-2032)
6 Global Bacillus Coagulans Sales by Region
- 6.1 Global Bacillus Coagulans Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bacillus Coagulans Sales by Region (2021-2032)
- 6.2.1 Global Bacillus Coagulans Sales by Region (2021-2026)
- 6.2.2 Global Bacillus Coagulans Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bacillus Coagulans Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bacillus Coagulans Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bacillus Coagulans Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bacillus Coagulans Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bacillus Coagulans Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bacillus Coagulans Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Bacillus Coagulans Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Bacillus Coagulans Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Bacillus Coagulans Revenue by Region
- 7.1 Global Bacillus Coagulans Revenue by Region
- 7.1.1 Global Bacillus Coagulans Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Bacillus Coagulans Revenue by Region (2021-2026)
- 7.1.3 Global Bacillus Coagulans Revenue by Region (2027-2032)
- 7.1.4 Global Bacillus Coagulans Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Bacillus Coagulans Revenue (2021-2032)
- 7.2.2 North America Bacillus Coagulans Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Bacillus Coagulans Revenue (2021-2032)
- 7.3.2 Europe Bacillus Coagulans Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Bacillus Coagulans Revenue (2021-2032)
- 7.4.2 Asia-Pacific Bacillus Coagulans Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Bacillus Coagulans Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Bacillus Coagulans Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Kerry
- 8.1.1 Kerry Company Information
- 8.1.2 Kerry Business Overview
- 8.1.3 Kerry Bacillus Coagulans Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Kerry Bacillus Coagulans Product Portfolio
- 8.1.5 Kerry Recent Developments
- 8.2 Sabinsa
- 8.2.1 Sabinsa Company Information
- 8.2.2 Sabinsa Business Overview
- 8.2.3 Sabinsa Bacillus Coagulans Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sabinsa Bacillus Coagulans Product Portfolio
- 8.2.5 Sabinsa Recent Developments
- 8.3 Mitsubishi
- 8.3.1 Mitsubishi Company Information
- 8.3.2 Mitsubishi Business Overview
- 8.3.3 Mitsubishi Bacillus Coagulans Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mitsubishi Bacillus Coagulans Product Portfolio
- 8.3.5 Mitsubishi Recent Developments
- 8.4 UAS Laboratories
- 8.4.1 UAS Laboratories Company Information
- 8.4.2 UAS Laboratories Business Overview
- 8.4.3 UAS Laboratories Bacillus Coagulans Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 UAS Laboratories Bacillus Coagulans Product Portfolio
- 8.4.5 UAS Laboratories Recent Developments
- 8.5 Synbiotech
- 8.5.1 Synbiotech Company Information
- 8.5.2 Synbiotech Business Overview
- 8.5.3 Synbiotech Bacillus Coagulans Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Synbiotech Bacillus Coagulans Product Portfolio
- 8.5.5 Synbiotech Recent Developments
- 8.6 Syngen Biotech
- 8.6.1 Syngen Biotech Company Information
- 8.6.2 Syngen Biotech Business Overview
- 8.6.3 Syngen Biotech Bacillus Coagulans Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Syngen Biotech Bacillus Coagulans Product Portfolio
- 8.6.5 Syngen Biotech Recent Developments
- 8.7 Sanzyme
- 8.7.1 Sanzyme Company Information
- 8.7.2 Sanzyme Business Overview
- 8.7.3 Sanzyme Bacillus Coagulans Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sanzyme Bacillus Coagulans Product Portfolio
- 8.7.5 Sanzyme Recent Developments
- 8.8 Microbax
- 8.8.1 Microbax Company Information
- 8.8.2 Microbax Business Overview
- 8.8.3 Microbax Bacillus Coagulans Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Microbax Bacillus Coagulans Product Portfolio
- 8.8.5 Microbax Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bacillus Coagulans Value Chain Analysis
- 9.1.1 Bacillus Coagulans Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bacillus Coagulans Production Mode & Process
- 9.2 Bacillus Coagulans Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bacillus Coagulans Distributors
- 9.2.3 Bacillus Coagulans Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst